Four patients presented two mutations: (1) ALL 001 had two different mutations in NRAS, (2) ALL 010 had mutations in JAK2 and KRAS, (3) ALL 017 had two different mutations in SH2B3, and (4) ALL 036 showed mutations in NRAS and USP9X. Here, JAK2 is linked to acute lymphoblastic leukemia.